Treffer 1 - 2 von 2 für Suche 'Luo, Jingqin Rosy', Suchdauer: 0,33s Treffer weiter einschränken
  1. 1
    31. A Phase I/II trial of ATI-2231 with Phase Ia in advanced soild tumor malignancies followed by Phase Ib/II in combination with capecitabine in patients with hormone receptor-positive (HR+) and HER2-negative metastatic breast cancer

    31. A Phase I/II trial of ATI-2231 with Phase Ia in advanced soild tumor malignancies followed by Phase Ib/II in combination with capecitabine in patients with hormone receptor-pos... von Clifton, Katherine, Luo, Jingqin Rosy, Civitelli, Roberto, Geisler, Stefanie, Khan, Qamar, O'Sullivan, Ciara, Aggarwal, Ajay, Stewart, Sheila, Ma, Cynthia

    Veröffentlicht in Journal of bone oncology

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    CTIM-24. PHASE II TRIAL OF RHIL-7-HYFC IN PATIENTS WITH HIGH-GRADE GLIOMA DEMONSTRATED ACCEPTABLE SAFETY PROFILE AND REDUCED LYMPHOPENIA

    CTIM-24. PHASE II TRIAL OF RHIL-7-HYFC IN PATIENTS WITH HIGH-GRADE GLIOMA DEMONSTRATED ACCEPTABLE SAFETY PROFILE AND REDUCED LYMPHOPENIA von Derek Li, Yuping, Luo, Jingqin Rosy, Grote, Cierra, Nehring, Leslie, Katumba, Ruth, Etter, Kelsey, Barozinsky, Kaiden, Ferrando-Martinez, Sara, Stermer, Kristina, Lee, Byung Ha, Johanns, Tanner, Butt, Omar, Huang, Jiayi, Campian, Jian L, Chheda, Milan G


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: